Omega-3 Supplements Linked to Fewer Pain Crises in Children With Sickle Cell Disease
In children with sickle cell disease, adding omega-3 to standard therapy was linked to fewer and less severe pain crises than standard therapy alone.
A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
In children with sickle cell disease, adding omega-3 to standard therapy was linked to fewer and less severe pain crises than standard therapy alone.
In neonatal piglets, a plant-based omega-3 IV nutrition formula was linked to less brain inflammation and stronger energy and growth signaling in the brain compared to a fish-oil-based formula.
Nursing mothers who took DHA supplements for 150 days had higher breast milk DHA levels, and their infants showed better growth and neurodevelopmental scores than infants of non-supplemented mothers.
Women with the highest omega-3 (EPA+DHA) intake had a higher live birth rate and lower pregnancy loss during fertility treatment than those with the lowest intake.
Modern diets have shifted from an ancestral omega-6 to omega-3 ratio of about 1:1 to as high as 25:1, a change linked to brain and cell membrane composition.
Combining gene-marking, gene-activity, and genetic data suggests omega-3 fatty acids may influence aging-related biology partly through changes in gut bacteria and gene regulation.